GCM
ALAB icon

Gables Capital Management’s Astera Labs ALAB Stock Holding History

Gables Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$438K Buy
+4,000
New +$570K 0.19% 89

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Gables Capital Management's ALAB Position: Q1 2026 in Review

Gables Capital Management opened a new position in Astera Labs (ALAB) in Q1 2026: 4,000 shares worth $438K. The stake represents 0.19% of the portfolio and ranks #89 among its holdings.

703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Gables Capital Management held 4,000 shares of Astera Labs worth $438K as of Q1 2026.
  • Astera Labs was a new Gables Capital Management position in Q1 2026.
  • Astera Labs made up 0.19% of Gables Capital Management's portfolio in Q1 2026, its #89 holding.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Gables Capital Management's 13F filing for Q1 2026, filed 1 May 2026.